Health ❯ Healthcare Policy

Drug Pricing

Pharmaceutical Companies Prescription Drugs Executive Orders Generic Medications Insurance Coverage Pharmaceutical Agreements Consumer Protection Pharmaceutical Imports Market Regulations Access to Medications Market Regulation Novo Nordisk Generic Competition Insulin Costs Affordability U.S. Policies Import Policies Transparency in Healthcare Inflation Reduction Act Pharmaceutical Industry

Sandoz Agrees to $478.5 Million U.S. Settlement Over Generic Drug Pricing

The deal would resolve most state and reseller claims while leaving some opt-out suits and a 2027 trial as outstanding legal risks.

RFK Jr. Sets Year 2 Health Push, Calling Ultra-Processed Foods a National Crisis